A detailed history of Gateway Advisory, LLC transactions in Amgen Inc stock. As of the latest transaction made, Gateway Advisory, LLC holds 871 shares of AMGN stock, worth $280,644. This represents 0.05% of its overall portfolio holdings.

Number of Shares
871
Previous 871 -0.0%
Holding current value
$280,644
Previous $247,000 10.12%
% of portfolio
0.05%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $23,391 - $28,236
87 Added 11.1%
871 $247,000
Q4 2023

Feb 07, 2024

BUY
$255.7 - $288.46 $200,468 - $226,152
784 New
784 $225,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $172B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Gateway Advisory, LLC Portfolio

Follow Gateway Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gateway Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gateway Advisory, LLC with notifications on news.